9,10-dimethyl-1,2-benzanthracene has been researched along with selegiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felten, DL; Felten, SY; ThyagaRajan, S | 1 |
| Felten, DL; Madden, KS; Stevens, SY; ThyagaRajan, S | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and selegiline
| Article | Year |
|---|---|
Antitumor effect of L-deprenyl in rats with carcinogen-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Body Weight; Chromatography, High Pressure Liquid; Dopamine; Female; Hypothalamus, Middle; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Neuroprotective Agents; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Time Factors | 1998 |
Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors.
Topics: 3,4-Dihydroxyphenylacetic Acid; 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Division; Female; Flow Cytometry; Hydroxyindoleacetic Acid; Immune System; Interferon-gamma; Interleukin-2; Killer Cells, Natural; Mammary Neoplasms, Experimental; Monoamine Oxidase Inhibitors; Neuroimmunomodulation; Norepinephrine; Rats; Rats, Sprague-Dawley; Selegiline; Serotonin; Spleen; Sympathetic Nervous System; Synaptic Transmission; T-Lymphocytes | 2000 |